Kaul S, Finkelstein D M, Homma S, Leavitt M, Okada R D, Boucher C A
Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston.
J Am Coll Cardiol. 1988 Jul;12(1):25-34. doi: 10.1016/0735-1097(88)90351-8.
The purpose of this study was to determine the prognostic utility of quantitative exercise thallium-201 imaging and compare it with that of cardiac catheterization in ambulatory patients. Accordingly, long-term (4 to 9 years) follow-up was obtained in 293 patients who underwent both tests for the evaluation of chest pain: 89 had undergone coronary artery bypass graft surgery within 3 months of testing and were excluded from analysis, 119 experienced no cardiac events and 91 had an event (death in 20, nonfatal myocardial infarction in 21 and coronary artery bypass operations performed greater than 3 months after cardiac catheterization in 50). When all variables were analyzed using Cox regression analysis, the quantitatively assessed lung/heart ratio of thallium-201 activity was the most important predictor of a future cardiac event (chi 2 = 40.21). Other significant predictors were the number of diseased vessels (chi 2 = 17.11), patient gender (chi 2 = 9.43) and change in heart rate from rest to exercise (chi 2 = 4.19). Whereas the number of diseased vessels was an important independent predictor of cardiac events, it did not add significantly to the overall ability of the exercise thallium-201 test to predict events. Furthermore, information obtained from thallium-201 imaging alone was marginally superior to that obtained from cardiac catheterization alone (p = 0.04) and significantly superior to that obtained from exercise testing alone (p = 0.02) in determining the occurrence of events. In addition, unlike the exercise thallium-201 test, which could predict the occurrence of all categories of events, catheterization data were not able to predict the occurrence of nonfatal myocardial infarction. The exclusion of bypass surgery and previous myocardial infarction did not alter the results. In conclusion, data from this study demonstrate that exercise thallium-201 imaging may be superior to data from both exercise testing alone and cardiac catheterization data alone for predicting future events in ambulatory patients who have undergone both exercise thallium-201 imaging and catheterization for the evaluation of chest pain.
本研究的目的是确定定量运动铊-201心肌显像的预后价值,并将其与动态患者的心导管检查结果进行比较。为此,对293例因胸痛接受这两项检查的患者进行了长期(4至9年)随访:89例在检查后3个月内接受了冠状动脉搭桥手术,被排除在分析之外;119例未发生心脏事件,91例发生了事件(20例死亡,21例非致命性心肌梗死,50例在心脏导管检查后3个月以上进行了冠状动脉搭桥手术)。当使用Cox回归分析对所有变量进行分析时,定量评估的铊-201活性肺/心比值是未来心脏事件最重要的预测指标(χ2 = 40.21)。其他显著的预测指标包括病变血管数量(χ2 = 17.11)、患者性别(χ2 = 9.43)以及静息心率到运动心率的变化(χ2 = 4.19)。虽然病变血管数量是心脏事件的重要独立预测指标,但它对运动铊-201试验预测事件的总体能力并没有显著增强。此外,仅从铊-201显像获得的信息在确定事件发生方面略优于仅从心导管检查获得的信息(p = 0.04),且显著优于仅从运动试验获得的信息(p = 0.02)。此外,与能够预测所有类型事件发生的运动铊-201试验不同,导管检查数据无法预测非致命性心肌梗死的发生。排除搭桥手术和既往心肌梗死病例并不改变结果。总之,本研究数据表明,对于已经接受运动铊-201显像和心导管检查以评估胸痛的动态患者,运动铊-201显像在预测未来事件方面可能优于单独的运动试验数据和单独的心导管检查数据。